Observational studyBreast (Edinburgh, Scotland)2026

Impact of trastuzumab deruxtecan (T-DXd) and brain stereotactic radiosurgery on intracranial control and radionecrosis risk in HER2-positive or -low breast cancer brain metastases.

Seok-Joo Chun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.